BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 28939464)

  • 1. Milling solid proteins to enhance activity after melt-encapsulation.
    Lee PW; Maia J; Pokorski JK
    Int J Pharm; 2017 Nov; 533(1):254-265. PubMed ID: 28939464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hot Melt Extrusion for Sustained Protein Release: Matrix Erosion and In Vitro Release of PLGA-Based Implants.
    Cossé A; König C; Lamprecht A; Wagner KG
    AAPS PharmSciTech; 2017 Jan; 18(1):15-26. PubMed ID: 27193002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of Lysozyme-PLGA-Loaded Microparticles for Controlled Release Using Hot-Melt Extrusion.
    Farinha S; Moura C; Afonso MD; Henriques J
    AAPS PharmSciTech; 2020 Oct; 21(7):274. PubMed ID: 33033873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEGylation to Improve Protein Stability During Melt Processing.
    Lee P; Towslee J; Maia J; Pokorski J
    Macromol Biosci; 2015 Oct; 15(10):1332-7. PubMed ID: 26097064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Injectable Sustained-Release Depots of PLGA Microspheres for Insoluble Drugs Prepared by hot-Melt Extrusion.
    Guo Y; Yang Y; He L; Sun R; Pu C; Xie B; He H; Zhang Y; Yin T; Wang Y; Tang X
    Pharm Res; 2017 Oct; 34(10):2211-2222. PubMed ID: 28741064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving release completeness from PLGA-based implants for the acid-labile model protein ovalbumin.
    Duque L; Körber M; Bodmeier R
    Int J Pharm; 2018 Mar; 538(1-2):139-146. PubMed ID: 29355654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the covalent modification with poly(ethylene glycol) on alpha-chymotrypsin stability upon encapsulation in poly(lactic-co-glycolic) microspheres.
    Castellanos IJ; Al-Azzam W; Griebenow K
    J Pharm Sci; 2005 Feb; 94(2):327-40. PubMed ID: 15570602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved lysozyme stability and release properties of poly(lactide-co-glycolide) implants prepared by hot-melt extrusion.
    Ghalanbor Z; Körber M; Bodmeier R
    Pharm Res; 2010 Feb; 27(2):371-9. PubMed ID: 20033474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyethylene glycol as an alternative polymer solvent for nanoparticle preparation.
    Ali ME; Lamprecht A
    Int J Pharm; 2013 Nov; 456(1):135-42. PubMed ID: 23958752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structured Biodegradable Polymeric Microparticles for Drug Delivery Produced Using Flow Focusing Glass Microfluidic Devices.
    Ekanem EE; Nabavi SA; Vladisavljević GT; Gu S
    ACS Appl Mater Interfaces; 2015 Oct; 7(41):23132-43. PubMed ID: 26423218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of microencapsulation method and peptide loading on formulation of poly(lactide-co-glycolide) insulin nanoparticles.
    Kumar PS; Ramakrishna S; Saini TR; Diwan PV
    Pharmazie; 2006 Jul; 61(7):613-7. PubMed ID: 16889069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the preparation progress of protein/peptide drug loaded PLA/PLGA microspheres.
    Xu FH; Zhang Q
    Yao Xue Xue Bao; 2007 Jan; 42(1):1-7. PubMed ID: 17520799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLGA-based monolithic filaments prepared by hot-melt extrusion: In-vitro comparative study.
    Kamel R; Abbas H
    Ann Pharm Fr; 2018 Mar; 76(2):97-106. PubMed ID: 29145995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein release from electrospun nonwovens: improving the release characteristics through rational combination of polyester blend matrices with polidocanol.
    Puhl S; Ilko D; Li L; Holzgrabe U; Meinel L; Germershaus O
    Int J Pharm; 2014 Dec; 477(1-2):273-81. PubMed ID: 25445519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulation-free controlled release: Electrostatic adsorption eliminates the need for protein encapsulation in PLGA nanoparticles.
    Pakulska MM; Elliott Donaghue I; Obermeyer JM; Tuladhar A; McLaughlin CK; Shendruk TN; Shoichet MS
    Sci Adv; 2016 May; 2(5):e1600519. PubMed ID: 27386554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the therapeutic efficacy of prilocaine by PLGA microparticles: Preparation, characterization and in vivo evaluation.
    Bragagni M; Gil-Alegre ME; Mura P; Cirri M; Ghelardini C; Di Cesare Mannelli L
    Int J Pharm; 2018 Aug; 547(1-2):24-30. PubMed ID: 29800738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
    Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
    J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of salts on lysozyme stability at the water-oil interface and upon encapsulation in poly(lactic-co-glycolic) acid microspheres.
    Pérez C; Griebenow K
    Biotechnol Bioeng; 2003 Jun; 82(7):825-32. PubMed ID: 12701149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured microspheres produced by supercritical fluid extraction of emulsions.
    Della Porta G; Reverchon E
    Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.